About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Stroke Recovery Research Based on EEG-fMRI | Clinical Trials | Clareo Health

Back to clinical trial search

COMPLETEDNCT05427422

Stroke Recovery Research Based on EEG-fMRI

This study is aimed to investigate the post-stroke motor recovery of patients with ischemic stroke based on their neural features extracted from EEG-fMRI data.

Lead sponsor: Xi'an Jiaotong University•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Sponsors

Lead Sponsor

Xi'an Jiaotong University

Collaborators

Xian Daxing Hospital

A group of patients with ischemic stroke and age/gender matched healthy controls would be enrolled in this study. Their features of neural activities based on EEG-fMRI fusion scan would be extracted to investigate the mechanisms of motor recovery after stroke. Particularly, the correlations of their features of neural networks or local activities to their motor function (defined as their Fugl-Meyer scores) at enrollment and their recovery time courses consisted of Fugl-Meyer scores in follow-up time points. Data of T1 structural, DSI fiber image and pure EEG (without MRI) would also be collected along with EEG-fMRI fusion data.

Age

18 - 75 years

Sex

ALL

Healthy Volunteers

Yes

Inclusion Criteria

•Age above 18 and below 75 years
•Motor impairment in National Institutes of Health Stroke Scale
•7-14 days since stroke attack
•First-ever ischemic stroke

Exclusion Criteria

•Motor impairment induced by non-stroke aetiology
•Claustrophobia; recognition disorder
•History of other severe central nervous system diseases
•Any signs unfit for MRI/EEG scan

Related studies

RECRUITINGPhase 3

A Study to Assess the Efficacy and Safety of Empasiprubart Versus IVIg in Adults With Multifocal Motor Neuropathy

NCT06742190 · Multifocal Motor Neuropathy (MMN), MMN

RECRUITINGPhase 2

A Clinical Study to Evaluate DNTH103 in Adults With Multifocal Motor Neuropathy

NCT06537999 · Multifocal Motor Neuropathy

Neuromuscular Electrical Stimulation Versus Low-intensity Laser on Motor Conduction Velocity of the Common Peroneal Nerve Post Burn

NCT06478914 · Neuropathy, Peroneal, Motor Neuropathy, and more

Autologous Stem/Stromal Cells in Neurological Disorders and Disease

NCT03297177 · Dementia, Parkinson, and more

COMPLETEDPhase 2

Efficacy and Safety of HyQvia (Immunoglobulin 10% With Recombinant Hyaluronidase) in Multifocal Motor Neuropathy (MMN)

NCT02556437 · Multifocal Motor Neuropathy

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: September 19, 2024Terms

Trial snapshot

StatusCOMPLETED

Phase—

Enrollment147

Start dateJun 2022

Last updatedSep 19, 2024

Condition

Motor Neuropathy

Locations shown

Xi'an Daxing Hospital

Xi’an, Shanxi

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: September 19, 2024Data synced to Clareo: May 25, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions